Wambolt & Associates LLC lowered its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 15.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 30,982 shares of the company’s stock after selling 5,770 shares during the quarter. Wambolt & Associates LLC’s holdings in Corteva were worth $1,765,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Mitsubishi UFJ Trust & Banking Corp raised its holdings in Corteva by 0.6% during the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 333,616 shares of the company’s stock worth $19,003,000 after buying an additional 1,828 shares during the period. Baxter Bros Inc. raised its holdings in shares of Corteva by 1.6% during the fourth quarter. Baxter Bros Inc. now owns 15,012 shares of the company’s stock valued at $855,000 after acquiring an additional 236 shares during the period. TIAA Trust National Association lifted its position in shares of Corteva by 7.6% in the 4th quarter. TIAA Trust National Association now owns 13,748 shares of the company’s stock valued at $783,000 after acquiring an additional 975 shares in the last quarter. Modern Wealth Management LLC boosted its stake in Corteva by 33.2% in the 4th quarter. Modern Wealth Management LLC now owns 5,775 shares of the company’s stock worth $359,000 after purchasing an additional 1,440 shares during the period. Finally, CoreFirst Bank & Trust acquired a new stake in Corteva during the 4th quarter valued at $50,000. 81.54% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the company. Citigroup increased their price objective on Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. BNP Paribas raised Corteva to a “hold” rating in a research note on Monday, February 10th. Barclays boosted their price target on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 21st. Royal Bank of Canada raised their price objective on shares of Corteva from $72.00 to $73.00 and gave the company an “outperform” rating in a research report on Friday, February 7th. Finally, KeyCorp boosted their target price on shares of Corteva from $68.00 to $70.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.00.
Insider Activity
In other Corteva news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now directly owns 11,347 shares in the company, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.14% of the stock is owned by company insiders.
Corteva Stock Up 0.7 %
Shares of CTVA opened at $62.12 on Tuesday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The company has a 50-day simple moving average of $62.48 and a 200-day simple moving average of $59.95. Corteva, Inc. has a 52 week low of $50.01 and a 52 week high of $66.24. The firm has a market capitalization of $42.59 billion, a P/E ratio of 48.16, a P/E/G ratio of 1.68 and a beta of 0.79.
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. On average, equities research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.
Corteva Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date was Monday, March 3rd. Corteva’s payout ratio is 52.71%.
Corteva Company Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also
- Five stocks we like better than Corteva
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Boeing Breaks Out: What the Market Is Signaling Now
- The Risks of Owning Bonds
- Quantum Gamble? Is IonQ’s Stock an Opportunity or a Mirage?
- Retail Stocks Investing, Explained
- 4 Stocks Raising Dividends by More Than 10%
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.